TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $387,417 | +25.1% | 10,214 | -19.8% | 0.00% | 0.0% |
| Q1 2023 | $309,642 | -16.3% | 12,732 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $370,115 | +10.8% | 12,745 | +14.4% | 0.00% | 0.0% |
| Q3 2022 | $334,000 | -9.7% | 11,145 | +8.8% | 0.00% | 0.0% |
| Q2 2022 | $370,000 | -21.4% | 10,245 | -6.0% | 0.00% | 0.0% |
| Q1 2022 | $471,000 | -15.4% | 10,898 | -2.0% | 0.00% | 0.0% |
| Q4 2021 | $557,000 | -19.0% | 11,125 | +2.9% | 0.00% | 0.0% |
| Q3 2021 | $688,000 | -15.8% | 10,809 | -4.8% | 0.00% | -50.0% |
| Q2 2021 | $817,000 | +5.0% | 11,350 | +7.6% | 0.00% | 0.0% |
| Q1 2021 | $778,000 | -4.1% | 10,550 | -4.5% | 0.00% | 0.0% |
| Q4 2020 | $811,000 | +30.2% | 11,050 | -2.6% | 0.00% | 0.0% |
| Q3 2020 | $623,000 | +2.5% | 11,350 | +24.0% | 0.00% | 0.0% |
| Q2 2020 | $608,000 | +14.1% | 9,150 | +5.1% | 0.00% | 0.0% |
| Q1 2020 | $533,000 | -30.3% | 8,705 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $765,000 | -62.4% | 8,705 | -67.7% | 0.00% | -60.0% |
| Q3 2019 | $2,034,000 | -13.8% | 26,957 | -2.4% | 0.01% | -37.5% |
| Q2 2019 | $2,359,000 | -8.8% | 27,622 | +15.5% | 0.01% | -11.1% |
| Q1 2019 | $2,586,000 | +299.1% | 23,925 | +262.7% | 0.01% | +350.0% |
| Q4 2018 | $648,000 | 0.0% | 6,597 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $648,000 | -37.3% | 6,597 | -26.1% | 0.00% | -50.0% |
| Q2 2018 | $1,033,000 | -25.9% | 8,922 | -36.8% | 0.00% | -20.0% |
| Q1 2018 | $1,395,000 | -6.9% | 14,128 | -1.2% | 0.01% | 0.0% |
| Q4 2017 | $1,498,000 | +30.6% | 14,306 | +40.4% | 0.01% | +25.0% |
| Q3 2017 | $1,147,000 | +22.3% | 10,186 | +21.7% | 0.00% | 0.0% |
| Q2 2017 | $938,000 | +3.4% | 8,372 | +7.7% | 0.00% | 0.0% |
| Q1 2017 | $907,000 | -23.3% | 7,775 | -30.8% | 0.00% | -33.3% |
| Q4 2016 | $1,183,000 | -9.6% | 11,234 | -5.1% | 0.01% | -14.3% |
| Q3 2016 | $1,309,000 | +450.0% | 11,843 | +625.2% | 0.01% | +600.0% |
| Q2 2016 | $238,000 | +13.3% | 1,633 | +11.5% | 0.00% | 0.0% |
| Q1 2016 | $210,000 | +320.0% | 1,464 | +349.1% | 0.00% | – |
| Q4 2015 | $50,000 | – | 326 | – | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2015 | $54,000 | +1.9% | 376 | 0.0% | 0.00% | – |
| Q1 2015 | $53,000 | -77.5% | 376 | -76.4% | 0.00% | -100.0% |
| Q4 2014 | $236,000 | – | 1,595 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |